VanEck Biotech ETF
BBH
101 hedge funds and large institutions have $131M invested in VanEck Biotech ETF in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 29 reducing their positions, and 12 closing their positions.
67% more call options, than puts
Call options by funds: $1.22M | Put options by funds: $729K
2% more capital invested
Capital invested by funds: $129M → $131M (+$2.1M)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
0.51% less ownership
Funds ownership: 27.36% → 26.85% (-0.51%)
1% less funds holding
Funds holding: 102 → 101 (-1)
17% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wealthspire Advisors (Maryland)
Potomac,
Maryland
|
+$1.18M |
| 2 |
SFPG
Stonebridge Financial Planning Group
Orlando,
Florida
|
+$1.05M |
| 3 |
PAG
Pinnacle Advisory Group
Columbia,
Maryland
|
+$959K |
| 4 |
FTUS
Flow Traders U.S.
New York
|
+$949K |
| 5 |
WANY
Wealthspire Advisors (New York)
New York
|
+$728K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$2.05M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.58M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.57M |
| 4 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$1.55M |
| 5 |
LPL Financial
San Diego,
California
|
-$1.37M |
BBH Hedge Fund Activity: Q3 2020 in Review
101 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2020, worth a combined $131M — up 1.6% from $129M a quarter earlier.
Fund positioning in BBH was balanced in Q3 2020: 12 funds opened new positions, 12 closed out, 24 added to existing stakes and 29 trimmed.
The largest buyer was Wealthspire Advisors (Maryland), opening a new position worth an estimated $1.18M. The largest seller was Envestnet Asset Management, cutting an estimated $2.05M.
- 101 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2020, down from 102 in Q2 2020.
- Funds reported $131M of VanEck Biotech ETF stock for Q3 2020, up 1.6% quarter-over-quarter.
- 12 funds opened new VanEck Biotech ETF positions in Q3 2020 and 12 closed out, a net change of 0 holders.
- The largest VanEck Biotech ETF buyer in Q3 2020 was Wealthspire Advisors (Maryland), an estimated $1.18M added.
- The largest VanEck Biotech ETF seller in Q3 2020 was Envestnet Asset Management, an estimated $2.05M sold.
Based on aggregated 13F filings for Q3 2020.